BackBioLASCO Taiwan , Ltd. Overview

BioLASCO Taiwan , Ltd. Current Cash

BioLASCO Taiwan , Ltd.'s current cash is $86M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$85.57M
↓ 18.98% YoYΔ $-20.05M vs prior year quarter

Peer trimmed avg / median

Loading

BioLASCO Taiwan , Ltd. Current Cash History

Loading

BioLASCO Taiwan , Ltd. vs. peers: Current Cash Comparison

Loading

BioLASCO Taiwan , Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioLASCO Taiwan , Ltd. (6662.TWO) FAQ

As of the most recent data (June 2026), 6662.TWO shows a current cash of $86M. That compares with $110M in the prior-year period — down 19.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6662.TWO's current cash is now $86M (was $110M) — a 19.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioLASCO Taiwan , Ltd. is outperforming or lagging.

Tracking 6662.TWO's current cash over time shows whether BioLASCO Taiwan , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $86M That compares with $110M in the prior-year period — down 19.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has BioLASCO Taiwan , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $86M) with ownership activity and broader fundamentals.

BioLASCO Taiwan , Ltd.'s current cash is $86M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.